They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...

Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

This week, President Donald Trump called Operation Warp Speed, a public-private federal program that helped speed up the ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

(Reuters) -Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...